Headlands Technologies’s Novo Nordisk NVO Stock Holding History

Headlands Technologies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,054	Closed	-$1.12M	–	897
2025 Q4	$1.12M	Buy	+22,054	New	+$1.13M	0.09%	250
2025 Q1	–	Sell	-10,385	Closed	-$893K	–	1402
2024 Q4	$893K	Buy	+10,385	New	+$1.12M	0.09%	232
2024 Q3	–	Sell	-22,323	Closed	-$3.19M	–	1427
2024 Q2	$3.19M	Buy	22,323 +5,607	+34%	+$743K	0.34%	62
2024 Q1	$2.15M	Buy	16,716 +13,859	+485%	+$1.65M	0.52%	38
2023 Q4	$296K	Buy	2,857 +711	+33%	+$70.3K	0.09%	210
2023 Q3	$195K	Buy	+2,146	New	+$189K	0.1%	206

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Headlands Technologies's NVO Position: Q1 2026 in Review

Headlands Technologies sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 22,054 shares — an estimated $1.12M sold.

Headlands Technologies first reported a position in NVO in Q3 2023 and held it in 6 quarters. The position peaked at $3.19M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Headlands Technologies reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Headlands Technologies sold 22,054 Novo Nordisk shares in Q1 2026, an estimated $1.12M.
Headlands Technologies first reported a position in Novo Nordisk in Q3 2023 and held it in 6 quarters.
Headlands Technologies's Novo Nordisk position peaked at $3.19M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.